DateDescription of Events
12/28/84Biopsy: Left breast pathology: 8 mm well-differentiated ductal cell carcinoma with microcalcification and stromal infiltration with comedo-carcinoma features
12/28/84Surgery: left partial mastectomy for diagnosis and palliation.
12/28/84X-ray chest: within normal limits
4/18/85X-ray chest: within normal limits
4/19/85Surgery left axilla: moderately differentiated ductal cell carcinoma, 29/30 nodes positive
4/22/85ERA binding sites: 13.9 fmol/mg, Estradiol receptor cytosol protein 2 mg/ml; PRA binding sites 219.3 fmol/mg; Progesterone receptor cytosol protein 4 mg/ml
4/22/85Radiation recommended for palliation; patient refused due to personal preference
4/22/85Liver scan: borderline hepatomegaly
4/23/85Bone scan: within normal limits
7/8/86Bone scan: within normal limits
7/8/86X-ray chest: within normal limits
3/6/87X-ray chest
12/2/87Bone scan: within normal limits
12/2/87X-ray chest: within normal limits
5/14/85Vitamin C, beta carotene, vitamin E, selenium, multivitamin
5/14/85–3/3/94IAT 18 courses

From: Appendix E: Additional Cases Reviewed

Cover of Best-Case Series for the Use of Immuno-Augmentation Therapy and Naltrexone for the Treatment of Cancer
Best-Case Series for the Use of Immuno-Augmentation Therapy and Naltrexone for the Treatment of Cancer.
Evidence Reports/Technology Assessments, No. 78.
Coulter I, Hardy M, Shekelle P, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.